Responses
Basic and translational research
Extended report
Tocilizumab in patients with active rheumatoid arthritis and inadequate responses to DMARDs and/or TNF inhibitors: a large, open-label study close to clinical practice
Compose a Response to This Article
Other responses
No responses have been published for this article.